OCGN$0.70275.58%-0.0415
After Hours: 0.72+0.02 +2.46%
Ocugen Inc (OCGN)
Date: 2026-10-30 16:00O: 0.7460H: 0.7600L: 0.6909C: 0.7027Vol: 5.347M
Ocugen Inc stock is traded at $0.7027, with a volume of 5,347,075. It is down -5.58% in the last 24 hours and down -31.78% over the past month. Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
Previous Close:
$0.7442
Open:
$0.746
24h Volume:
5,347,075
Relative Volume:
0.79
Market Cap:
$238.29M
Revenue:
$4.47M
Net Income/Loss:
-$71.67M
P/E Ratio:
-
EPS:
-$0.2318
Net Cash Flow:
-$59.58M
1W Performance:
-5.00%
1M Performance:
-31.78%
6M Performance:
-59.38%
1Y Performance:
-52.52%
1-Day Range:
$0.6909$0.76
1-Week Range:
$0.6909$0.8037
52-Week Range:
$0.6909$2.73
Ocugen Inc Stock (OCGN) Company Profile
Name
Ocugen IncSector
HealthcareIndustry
BiotechnologyPhone
484-328-4701Address
11 GREAT VALLEY PARKWAY, MALVERN, PA, USACompare OCGN vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OCGN Ocugen Inc | $0.7027 | $238.29M | $4.47M | -$71.67M | -$59.58M | -$0.2318 |
 VRTX Vertex Pharmaceuticals Inc | $558.88 | $141.65B | $12.34B | $4.34B | $3.71B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $927.89 | $95.53B | $14.92B | $4.42B | $3.79B | $41.04 |
 MRNA Moderna Inc | $221.72 | $88.52B | $2.23B | -$3.19B | -$1.60B | -$8.15 |
 ARGX Argen X Se Adr | $892.87 | $56.15B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $370.33 | $41.89B | $5.76B | $514.49M | $1.10B | $4.48 |
Ocugen Inc Stock (OCGN) Upgrades & Downgrades
Ocugen Inc Stock (OCGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Ocugen Inc Stock (OCGN) Insider Trading
- Shankar MusunuriOct 09 '26Officer
- Transaction
- Proposed Sale
- Cost
- $0.95
- #Shares
- 525,991
- Value ($)
- 497,965
- #Shares Total
- 0
- Musunuri ShankarOct 09 '26Chief Executive Officer
- Transaction
- Sale
- Cost
- $0.95
- #Shares
- 57,264
- Value ($)
- 54,401
- #Shares Total
- 1,030,771
- Shankar MusunuriSep 09 '26Officer
- Transaction
- Proposed Sale
- Cost
- $1.12
- #Shares
- 525,991
- Value ($)
- 589,741
- #Shares Total
- 0
- Musunuri ShankarSep 09 '26Chief Executive Officer
- Transaction
- Sale
- Cost
- $1.12
- #Shares
- 57,264
- Value ($)
- 64,136
- #Shares Total
- 1,088,035
- Musunuri ShankarSep 09 '26Chief Executive Officer
- Transaction
- Sale
- Cost
- $1.12
- #Shares
- 468,727
- Value ($)
- 524,974
- #Shares Total
- 4,487,197
- Johnson-Greene Treerita EssaliJun 15 '26Chief Financial Officer
- Transaction
- Buy
- Cost
- $1.23
- #Shares
- 21,000
- Value ($)
- 25,830
- #Shares Total
- 521,000
- Zhang JungeApr 01 '26Director
- Transaction
- Option Exercise
- Cost
- $0.79
- #Shares
- 194,134
- Value ($)
- 154,303
- #Shares Total
- 1,359,316
